SCHEMBL7792074

SCHEMBL7792074

COc1cc(OC)c(C(F)(F)F)cc1C(=O)Nc1ccc2c(c1)CN(C)CC2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.51
CYP3A4 P08684 1/20 0.51
NPC1 O15118 4/20 0.47
KMT2A Q03164 4/20 0.47
RAB9A P51151 3/20 0.47
MEN1 O00255 3/20 0.47
MAPT P10636 2/20 0.46
TSHR P16473 2/20 0.46
MAPK1 P28482 2/20 0.46
TP53 P04637 1/20 0.46
ACHE P22303 1/20 0.44
DHODH Q02127 2/20 0.43
HTR2C P28335 1/20 0.43
HTR2B P41595 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
SLC6A4 P31645 1/20 0.43
MAP4K1 Q92918 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8184655 0.93 ROCK2 (0.51) ROCK2CYP3A4NPC1KMT2ARAB9A
SCHEMBL6293655 0.87 ROCK2 (0.61) ROCK2CYP3A4NPC1KMT2ARAB9A
SCHEMBL7657373 0.85 RAB9A (0.41) ROCK2CYP3A4NPC1KMT2ARAB9A
SCHEMBL8183644 0.85 ROCK2 (0.52) ROCK2CYP3A4NPC1KMT2ARAB9A
Hydrochloric Acid SCHEMBL7792070 0.83 NPC1 (0.59) ROCK2CYP3A4NPC1KMT2ARAB9A
SCHEMBL8184565 0.82 KMT2A (0.58) ROCK2CYP3A4NPC1KMT2ARAB9A
SCHEMBL8188782 0.81 ACHE (0.64) ROCK2CYP3A4NPC1RAB9AMAPT
SCHEMBL8186700 0.81 NR1H4 (0.55) ROCK2CYP3A4NPC1KMT2ARAB9A
SCHEMBL8077560 0.81 ROCK2 (0.42) ROCK2CYP3A4MAP4K1
SCHEMBL8185594 0.81 ALDH1A1 (0.59) ROCK2CYP3A4NPC1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants SMITHKLINE BEECHAM P.L.C. 2001-09-27 US disclosed
EP-1025087-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-08-09 EP disclosed
WO-1999021836-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants INA, GRIN2C, GRIN2A ROCK2 2314/4885CYP3A4 168/4885NPC1 852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.